Influence of Type I Interferons in Gammaherpesvirus-68 and Its Influence on EAE Enhancement

Ana Citlali Márquez1,2, Carys Croft3, Iryna Shanina1

  • 1Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.

Insights

Epstein-Barr virus (EBV) infection enhances experimental autoimmune encephalomyelitis (EAE) in mice. B cells from infected mice drive central nervous system inflammation, but type I interferons are not required for this enhanced EAE.

Area of Science:

  • Neuroimmunology
  • Virology
  • Immunology

Background:

  • Epstein-Barr virus (EBV) is implicated in multiple sclerosis (MS) pathogenesis.
  • Murine gammaherpesvirus 68 (γHV-68) infection in mice enhances experimental autoimmune encephalomyelitis (EAE), mimicking MS.
  • Previous studies identified CD40 on myeloid cells and B cell transfer as key factors in enhanced EAE.

Purpose of the Study:

  • To investigate the role of type I interferon (IFN) signaling in γHV-68-induced EAE enhancement.
  • To determine if B cells require type I IFN signaling to enhance EAE and drive CD8+ T cell infiltration into the central nervous system (CNS).

Main Methods:

  • Induction of EAE in γHV-68 latently infected mice, including those lacking type I IFN receptor (IFNARko).
  • Assessment of EAE severity, immune cell populations (CD4+, CD8+ T cells, Tregs), and cytokine profiles.
  • Transfer of B cells from infected mice to recipient mice.

Main Results:

  • B cells from γHV-68 infected mice enhance EAE by promoting CD8+ T cell CNS infiltration, independent of type I IFN signaling.
  • Type I IFNs are crucial for controlling γHV-68 infection and maintaining viral latency.
  • Type I IFN signaling does not directly influence the development of enhanced EAE in this model.

Conclusions:

  • B cells play a significant role in γHV-68-mediated EAE enhancement by facilitating CD8+ T cell entry into the CNS.
  • Type I interferons are dispensable for the exacerbation of EAE in latently infected mice, despite their importance in viral control.